IGF1R Gene Variants and Longevity: What Research Shows

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on longevity genetics. Browse all Longevity & Telomeres education

Few genes sit as close to the biology of aging as IGF1R, the receptor for insulin-like growth factor 1. Research in worms, flies, mice, and long-lived humans keeps pointing to the same theme: turning down growth-factor signaling, within limits, is associated with longer life. IGF1R is a central switch in that circuit, which is why its variants draw so much attention in longevity science.

IGF1R and the Insulin/IGF-1 Signaling Pathway

IGF1R encodes the cell-surface receptor that binds insulin-like growth factor 1. When IGF-1 docks, the receptor triggers a cascade that promotes cell growth, division, and survival. This insulin/IGF-1 signaling pathway is deeply conserved across species and helps balance a fundamental trade-off: growth and reproduction on one side, cellular maintenance and stress resistance on the other.

What Centenarian Studies Found About IGF1R

A landmark study of Ashkenazi Jewish centenarians reported that long-lived women were more likely to carry rare IGF1R variants that reduced the receptor's activity. These individuals tended to have higher circulating IGF-1, consistent with the body compensating for a less responsive receptor. The finding suggested that dampened IGF-1 signaling at the cellular level, rather than the hormone level alone, tracks with exceptional longevity.

Less Signaling, Longer Life? The Evolutionary Logic

The idea that reduced growth signaling can extend lifespan is one of the most robust findings in aging research. In model organisms, mutations that lower insulin/IGF-1 signaling reliably extend life and improve stress resistance. The leading explanation is that when growth signals quiet down, cells shift resources toward repair, autophagy, and protection — trading some growth for durability. IGF1R is one of the key nodes where this dial is set.

FOXO3: The Longevity Gene Downstream of IGF1R

Signals from IGF1R ultimately influence FOXO3, a transcription factor that switches on genes for stress defense, DNA repair, and antioxidant activity. The FOXO3 variant rs2802292 (the G allele) is one of the most replicated human longevity associations, tied to living to advanced age across Japanese, European, and other populations. Because FOXO3 sits downstream of IGF-1 signaling, IGF1R and FOXO3 are best understood as parts of one pathway rather than isolated genes.

Why This Is About Tendencies, Not Destiny

It is important to keep these findings in proportion. Longevity variants shift probabilities modestly; they do not guarantee a long life, and their absence does not doom anyone. Exceptional longevity reflects many genes interacting with a lifetime of environment, behavior, and luck. No single variant — including in IGF1R or FOXO3 — can be read as a lifespan prediction.

Where Genetic Insight Fits

Learning about longevity-associated pathways can be genuinely motivating, because the same biology responds to lifestyle. Exercise, sensible calorie balance, sleep, and metabolic health all influence insulin/IGF-1 signaling. Genetic insight offers educational context about these pathways, not a verdict on how long you will live — and it works best as one input a knowledgeable provider can help you interpret.

Frequently Asked Questions About IGF1R and Longevity

Does the IGF1R gene affect how long you live?

Research links certain IGF1R variants that lower receptor activity to exceptional longevity, especially in centenarian studies. Reduced insulin/IGF-1 signaling is associated with longer life across many species. However, the effect is a modest shift in probability, not a guarantee, and involves many other genes and lifestyle factors.

How are IGF1R and FOXO3 connected?

They belong to the same pathway. IGF1R sits at the top, receiving growth signals, while FOXO3 acts downstream, switching on genes for stress resistance and repair. The FOXO3 variant rs2802292 is a leading longevity association, and quieter IGF-1 signaling tends to keep FOXO3 more active.

Can a genetic test predict my lifespan?

No. A pathway-level genetic test offers educational context about longevity-related biology, not a lifespan prediction. It does not diagnose or prevent aging or disease. Genes are one modest input among many, and results are best interpreted with a qualified healthcare provider alongside your overall health picture.

Interested in the pathways that longevity research keeps returning to? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — offering educational, pathway-level context about the biology discussed here, not a diagnosis or a treatment plan. Your results are a starting point for a conversation with your provider, not the end of one.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, manage, or prevent any condition. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Longevity & Telomeres education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.